Advances in Hematological Malignancies
Recent years have witnessed remarkable strides in the field of hematological malignancies. Novel treatment modalities such as targeted agents, immunotherapies, and therapy are altering the survival rates for patients with blood cancers. Clinical trials continue to explore these innovative strategies, offering potential for more effective treatment